SphingoTec develops and markets innovative solutions for novel and proprietary blood-based protein biomarkers. Our aspiration is to effectively translate scientific advancements into routine clinical practice. We develop biomarkers addressing diagnostically underserved critical care conditions such as acute kidney injury, sepsis, and acute heart failure. First and foremost, our biomarkers support better management of critically ill patients, where fast and reliable information is of the essence in taking treatment decisions.
| Website | http://www.sphingotec.com |
| Employees | 20 (13 on RocketReach) |
| Founded | 2002 |
| Address | Neuendorfstraße, 15A, Hennigsdorf, Brandenburg 16761, DE |
| Industry | Biotechnology Research |
| Keywords | Biomarker Discovery, Diagnostic Biomarkers, Biomarker Development, Early Disease Detection, Innovative Diagnostics, Medical Diagnostics, Critical Care Diagnostics, Point Of Care Diagnostics, In Vitro Diagnostics, Diagnostics Technology, Clinical Diagnostics, Health Diagnostics |
| Competitors | Siemens Healthineers, Roche, Thermo Fisher Scientific, Abbott, Agilent Technologies, Hologic, Inc., bioMérieux, PerkinElmer, Inc., QuidelOrtho, Ortho Clinical Diagnostics - ANZ +37 more (view full list) |
Looking for a particular SphingoTec employee's phone or email?
SphingoTec Questions
Deborah Bergmann is the Managing Director and CEO of SphingoTec.
13 people are employed at SphingoTec.
SphingoTec is based in Hennigsdorf, Brandenburg.
Top SphingoTec Employees
-
Deborah Bergmann
Managing Director and CEO at SphingoTec
Hennigsdorf, BB, DE1 -
Susanne Jäkel
Head of Regulatory Affairs at SphingoTec
Hamburg, Hamburg, Germany1 -
Axel Schulze
Field Application Scientist at SphingoTec
Hennigsdorf, BB, DE1
Related Companies
